The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $655,146 in first-year total cost, median $232,875.
Most frequent study sections
- Cancer Etiology Study Section[CE]1
- Molecular Oncogenesis Study Section[MONC]1
- Tumor Cell Biology Study Section[TCB]1
Most frequent institutions
- UNIVERSITY OF NEBRASKA MEDICAL CENTER1
- UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON1
- VIRGINIA COMMONWEALTH UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Defining the role of Mst1/Mst2 in regulating metabolic alterations in Ras driven NSCLC1R21CA249924-01A1 | LUNDBERG, JENNIFER BAILEYYING, HAOQIANG | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $233,015 | TCB |
| 2021 | Novel Mechanisms Controlling SCLC Tumor Initiation1R21CA256638-01A1 | LEWIS, ROBERT E. | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $189,256 | MONC |
| 2020 | Role of the DREAM Complex in Head and Neck Preneoplasia1R21DE029927-01 | LITOVCHICK, LARISA | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $232,875 | CE |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.